NEW YORK, Jan. 29 - Boston University Medical Center has engaged Illumina to provide SNP-genotyping services for research into preterm birth.
Illumina will score a set of SNPs thought be linked with preterm birth and design SNP assays for the loci provided by Boston University.
Financial details were not disclosed.
San Diego-based Illumina has recently announced similar SNP-genotyping deals with Johns Hopkins Medical University Institute of Genetic Medicine and GlaxoSmithKline.
Illumina says that it can process nearly 1 million genotypes a day.